Aratana Therapeutics, Inc. | TalkMarkets

Latest Posts

About This Stock More About This Stock

5 Drug Stocks Poised To Surpass On Earnings This Quarter

Article By: Zacks Investment Research

Tuesday, April 17, 2018 3:13 PM EDT

The first-quarter earnings season has just kicked off.

In this article: LLY, PFE, ABBV, PETX, CTLT

Read

PETX Down Today, But Not Out

Article By: Gary Berman

Monday, February 6, 2017 4:16 PM EDT

PETX: The FIBOCALL view

In this article: PETX

Read

7 Stocks To Buy In The Market’s 3 Hottest Sectors

Article By: Bret Jensen

Saturday, July 30, 2016 1:58 PM EDT

Invest in the momentum of these seven stocks spanning three different sectors that all have strong economic tailwinds lifting their revenues, profits, and stock prices higher.

In this article: LVS, PGNX, AAPL, QCOM, PETX, LGIH, TMHC Also: TOL, RLYP

Read

Monday Morning Pre-Market Insights: GREK, SRPT, GCI, PETX

Article By: TipRanks

Monday, June 29, 2015 9:13 AM EDT

Monday Morning Pre-Market Insights: Global X Funds (GREK), Sarepta Therapeutics (SRPT), Gannett Co., Inc. (GCI), Aratana Therapeutics Inc (PETX).

In this article: GCI, GREK, PETX, SRPT

Read

Aratana Therapeutics Inc Hits 5-Month High On Positive Development

Article By: BioMedReports

Friday, December 19, 2014 4:30 PM EDT

After the announcement of positive results from the pivotal late-stage field study of its novel drug, AT-001 by Aratana Therapeutics Inc., its stock rose over 26% to $16.50.

In this article: PETX

Read

All Posts